Krishna Institute of Medical Sciences Ltd
NSE:KIMS

Watchlist Manager
Krishna Institute of Medical Sciences Ltd Logo
Krishna Institute of Medical Sciences Ltd
NSE:KIMS
Watchlist
Price: 645.45 INR 2.36% Market Closed
Market Cap: 258.3B INR

Krishna Institute of Medical Sciences Ltd
Investor Relations

Krishna Institute of Medical Sciences Ltd. (KIMS) has steadily carved out a significant presence in the Indian healthcare sector, rooted in the ethos of delivering accessible and high-quality care. Emerging from its base in Hyderabad, the institution has expanded its reach through a network of multispecialty hospitals spread across several states in southern and western India. KIMS has built its reputation on providing a broad spectrum of healthcare services, ranging from basic preventive care to advanced super specialty treatments. By blending cutting-edge medical technology with a team of experienced professionals, it has positioned itself as a destination for both domestic and international patients seeking reliable medical solutions.

The financial engine of KIMS runs on its comprehensive service offerings, which cater to a wide range of medical needs. Revenue streams are generated primarily through inpatient and outpatient services, surgical procedures, diagnostic services, and pharmacy sales. By maintaining a focus on operational efficiency and leveraging economies of scale, KIMS has managed to offer competitive pricing, thus broadening its accessibility. Furthermore, the institution has strategically enhanced its profitability through partnerships, expansions, and an emphasis on sustainability within its operations. This approach not only strengthens its market position but also fuels its capability to reinvest in infrastructure, research, and development, aiming for continuous growth and innovation in the healthcare landscape.

Show more
Loading

Earnings Calls

2024 Q4
Feb 13, 2025
Show Transcript
Previous
Next
Flow Traders Achieves Record Q4 Performance and Significant Annual Growth
2024 Q4
Feb 13, 2025

In the fourth quarter of 2024, Flow Traders experienced heightened market activity and volatility, driving a record net trading income of EUR 153.8 million—a 114% increase year-on-year. Total income for the year reached EUR 479.3 million, marking their second-best annual performance. Notably, the company saw substantial growth in ETP trading, with a 14% year-on-year increase. Their EBITDA margin improved to 52%, while net profit surged to EUR 63.2 million, translating to a basic EPS of EUR 1.47. For 2025, fixed operating expenses are expected to be EUR 190 million to EUR 210 million, amidst further diversification of trading capabilities and asset classes.

Show Full Analysis

Management

Dr. Bhaskara Rao Bollineni
Founder, Chairman & MD
No Bio Available
Dr. Abhinay Bollineni
CEO & Executive Director
No Bio Available
Mr. Sachin Ashok Salvi
Chief Financial Officer
No Bio Available
Ms. Anitha Dandamudi
Director of Operations & Wholetime Director
No Bio Available
Mr. Uma Shankar Mantha
Company Secretary, Compliance Officer & GM of Legal
No Bio Available
Mr. A. Rajender
Finance Controller
No Bio Available

Contacts

Address
TELANGANA
Secunderabad
1-8-31/1, Minister Rd, Krishna Nagar Colony, Begumpet
Contacts